Inventor · disambiguated record
Johan Selmer
Also filed as: SELMER JOHAN
6 granted patents·21 pending applications·154 citations·filing 1990–2021
84Inventor score
Files withNOVO NORDISK AS10LEO LABORATORIES LTD4KNUDSEN LOTTE B3DRUG DELIVERY SOLUTIONS1DRUG DELIVERY SOLUTIONS APS1
Top patents by PatentIndex Score
27 records- 0191US8088731B2Use of GLP-1 compound for treatment of critically ill patientsKNUDSEN LOTTE BJERRE·Filed 2009·Granted Jan 3, 2012·56 cites·28 claims
- 0281US5387503AAssay method using internal calibration to measure the amount of analyte in a sampleNOVO NORDISK AS·Filed 1991·Granted Feb 7, 1995·73 cites·55 claims
- 0375US6939853B2Combined use of a GLP-1 compound and another drug for treating dyslipidemiaNOVO NORDISK AS·Filed 2002·Granted Sep 6, 2005·9 cites·2 claims
- 0465US10806721B2Formulation for use in the treatment of uremic pruritusDRUG DELIVERY SOLUTIONS·Filed 2017·Granted Oct 20, 2020·1 cites·15 claims
- 0561US2008280815A1Lowering Serum LipidsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 0660US9713608B2Method for topically treating actinic keratosis on the trunk (except chest) or extremities with ingenol 3-(3,5-diethylisoxazole-4-carboxylate)LEO LABORATORIES LTD·Filed 2014·Granted Jul 25, 2017·0 cites·27 claims
- 0759US2009215688A1GLP-I Agonist And Cardiovascular ComplicationsNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 0857US2014206615A1Glp-1 agonist and cardiovascular complicationsNOVO NORDISK AS·Filed 2014·Application pending·0 cites
- 0956US2013338071A1GLP-1 Agonist and Cardiovascular ComplicationsNOVO NORDISK AS·Filed 2013·Application pending·0 cites
- 1055US2007167373A1Combined use of a GLP-1 compound and a modulator of diabetic late complicationsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1155US2007049531A1GLP-1 agonist and cardiovascular complationsKNUDSEN LISELOTTE B·Filed 2006·Application pending·0 cites
- 1254US2021000796A1Formulation for use in the treatment of uremic pruritusDRUG DELIVERY SOLUTIONS APS·Filed 2020·Application pending·0 cites
- 1354US2007207964A1Combined use of a GLP-1 compound and another drug for treating dyslipidemiaKNUDSEN LOTTE B·Filed 2007·Application pending·0 cites
- 1452US2006229248A1Use of GLP-1 compound for treatment of critically ill patientsKNUDSEN LOTTE B·Filed 2006·Application pending·0 cites
- 1552US2012295836A1GLP-I Agonist And Cardiovascular ComplicationsKNUDSEN LISELOTTE BJERRE·Filed 2012·Application pending·0 cites
- 1652US2023414699A1Treatment of dermatological conditionsMC2 THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1751US2011230409A1GLP-I Agonist And Cardiovascular ComplicationsNOVO NORDISK AS·Filed 2011·Application pending·0 cites
- 1850US2005256053A1Combined use of a GLP-1 compound and another drug for treating dyslipidemiaKNUDSEN LOTTE B·Filed 2005·Application pending·0 cites
- 1948US2003199445A1Use of GLP-1 compound for treatment of critically ill patientsFiled 2003·Application pending·0 cites
- 2047US2003144206A1Combined use of a GLP-1 compound and modulator of diabetic late complicationsFiled 2002·Application pending·0 cites
- 2146US2003220255A1GLP-1 agonist and cardiovascular complicationsFiled 2003·Application pending·0 cites
- 2245US2010184690A1Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late ComplicationsNOVO NORDISK AS·Filed 2010·Application pending·0 cites
- 2343US5165912AMethod for the detection of fibrinolytic activityNOVO NORDISK AS·Filed 1990·Granted Nov 24, 1992·15 cites·17 claims
- 2441US2016089362A1Method for Topically Treating Actinic Keratosis on the Trunk (except chest) or Extremities with Ingenol 3-(3,5-diethylisoxazole-4-carboxylate)LEO LAB LTD·Filed 2015·Application pending·0 cites
- 2532US2017258770A1Method for Topically Treating Actinic Keratosis on the Full Face or 250 cm2 on the Chest with Ingenol 3-(3,5-diethylisoxazole-4-carboxylate)LEO LABORATORIES LTD·Filed 2015·Application pending·0 cites
- 2632US2017258769A1A Method for Topically Treating Actinic Keratosis on the Trunk (except chest) and Extremities with Ingenol 3-(3,5-diethylisoxazole-4-carboxylate)LEO LABORATORIES LTD·Filed 2015·Application pending·0 cites
- 2725US2017258756A1A Method for Topically Treating Actinic Keratosis on the Scalp with Ingenol 3-(3,5-diethylisoxazole-4-carboxylate)LEO LABORATORIES LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Johan Selmer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →